Download
s41380-020-0791-8.pdf 1,38MB
WeightNameValue
1000 Titel
  • Clozapine modulates retinoid homeostasis in human brain and normalizes serum retinoic acid deficit in patients with schizophrenia
1000 Autor/in
  1. Regen, Francesca |
  2. Cosma, Nicoleta-Carmen |
  3. Otto, Lisa R. |
  4. Clemens, Vera |
  5. Saksone, Lana |
  6. Gellrich, Janine |
  7. Uesekes, Berk |
  8. Ta, Thi Minh Tam |
  9. Hahn, Eric |
  10. Dettling, Michael |
  11. Heuser, Isabella |
  12. Hellmann-Regen, Julian |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-06-02
1000 Erschienen in
1000 Quellenangabe
  • 26(9):5417-5428
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1038/s41380-020-0791-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589649/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • The atypical antipsychotic clozapine is one of the most potent drugs of its class, yet its precise mechanisms of action remain insufficiently understood. Recent evidence points toward the involvement of endogenous retinoic acid (RA) signaling in the pathophysiology of schizophrenia. Here we investigated whether clozapine may modulate RA-signaling. Effects of clozapine on the catabolism of all-trans RA (at-RA), the biologically most active metabolite of Vitamin A, were assessed in murine and human brain tissue and peripheral blood-derived mononuclear cells (PBMC). In patients with schizophrenia with and without clozapine treatment and matched healthy controls, at-RA serum levels and blood mRNA expression of retinoid-related genes in PBMCs were quantified. Clozapine and its metabolites potently inhibited RA catabolism at clinically relevant concentrations. In PBMC-derived microsomes, we found a large interindividual variability of the sensitivity toward the effects of clozapine. Furthermore, at-RA and retinol serum levels were significantly lower in patients with schizophrenia compared with matched healthy controls. Patients treated with clozapine exhibited significantly higher at-RA serum levels compared with patients treated with other antipsychotics, while retinol levels did not differ between treatment groups. Similarly, in patients without clozapine treatment, mRNA expression of RA-inducible targets CYP26A and STRA6, as well as at-RA/retinol ratio, were significantly reduced. In contrast, clozapine-treated patients did not differ from healthy controls in this regard. Our findings provide the first evidence for altered peripheral retinoid homeostasis in schizophrenia and suggest modulation of RA catabolism as a novel mechanism of action of clozapine, which may be useful in future antipsychotic drug development.
1000 Sacherschließung
lokal Leukocytes, Mononuclear [MeSH]
lokal Antipsychotic Agents/therapeutic use [MeSH]
lokal Humans [MeSH]
lokal Retinoids/therapeutic use [MeSH]
lokal Schizophrenia/drug therapy [MeSH]
lokal Schizophrenia
lokal Animals [MeSH]
lokal Brain [MeSH]
lokal Diagnostic markers
lokal Molecular biology
lokal Mice [MeSH]
lokal Article
lokal Tretinoin/therapeutic use [MeSH]
lokal Homeostasis [MeSH]
lokal Clozapine/pharmacology [MeSH]
lokal Clozapine/therapeutic use [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/UmVnZW4sIEZyYW5jZXNjYQ==|https://frl.publisso.de/adhoc/uri/Q29zbWEsIE5pY29sZXRhLUNhcm1lbg==|https://frl.publisso.de/adhoc/uri/T3R0bywgTGlzYSBSLg==|https://frl.publisso.de/adhoc/uri/Q2xlbWVucywgVmVyYQ==|https://frl.publisso.de/adhoc/uri/U2Frc29uZSwgTGFuYQ==|https://frl.publisso.de/adhoc/uri/R2VsbHJpY2gsIEphbmluZQ==|https://frl.publisso.de/adhoc/uri/VWVzZWtlcywgQmVyaw==|https://frl.publisso.de/adhoc/uri/VGEsIFRoaSBNaW5oIFRhbQ==|https://frl.publisso.de/adhoc/uri/SGFobiwgRXJpYw==|https://frl.publisso.de/adhoc/uri/RGV0dGxpbmcsIE1pY2hhZWw=|https://frl.publisso.de/adhoc/uri/SGV1c2VyLCBJc2FiZWxsYQ==|https://orcid.org/0000-0003-0411-9204
1000 Hinweis
  • DeepGreen-ID: f30c158898b64d02b7ef20bd3583ade7 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6471080.rdf
1000 Erstellt am 2023-11-18T10:47:34.618+0100
1000 Erstellt von 322
1000 beschreibt frl:6471080
1000 Zuletzt bearbeitet 2023-12-01T13:38:32.676+0100
1000 Objekt bearb. Fri Dec 01 13:38:32 CET 2023
1000 Vgl. frl:6471080
1000 Oai Id
  1. oai:frl.publisso.de:frl:6471080 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source